Nanomaterial-Facilitated Cyclin-Dependent Kinase 7 Inhibition Suppresses Gallbladder Cancer Progression via Targeting Transcriptional Addiction
Chen-Song Huang,Qiong-Cong Xu,Chunlei Dai,Liying Wang,Yi-Chih Tien,Fuxi Li,Qiao Su,Xi-Tai Huang,Jun Wu,Wei Zhao,Xiao-Yu Yin
DOI: https://doi.org/10.1021/acsnano.1c04570
IF: 17.1
2021-08-18
ACS Nano
Abstract:Gallbladder cancer (GBC) is the most aggressive malignancy of the biliary tract cancer, and there is a lack of effective treatment. Here, we developed a nanoparticle platform (8P4 NP) that can deliver THZ1, a cyclin-dependent kinase 7 (CDK7) inhibitor, to treat GBC. Analysis of datasets demonstrated that CDK7 was positively correlated with poor prognosis. CDK7 inhibition suppressed cell proliferation, induced apoptosis, and caused cell cycle block in GBC cells. THZ1 downregulated CDK7-mediated phosphorylation of RNA polymerase II (RNAPII), resulting in a significant downregulation of transcriptional programs, with a preferential repression of oncogenic transcription factors. To improve the tumor targeting efficiency of THZ1, 8P4 NPs were prepared and assembled with THZ1 to form NPs. Compared with free THZ1, NPs showed more advantages in prolonging blood circulation, escaping from lysosomes and increasing cellular uptake. Importantly, NPs demonstrated a more significant inhibition effect on GBC cells than free THZ1 in vitro. In addition, 8P4 NPs could efficiently deliver THZ1 to tumor sites in a patient-derived xenograft model of early recurrence, leading to tumor regression and transcriptional inhibition with minimal toxicity. In summary, we conclude that NPs provide a potent therapeutic strategy that targets CDK7-mediated transcriptional addiction in GBC.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsnano.1c04570.The synthetic route of 8-Phe-4 (8P4) polymer (Figure S1); correlation of CDK7 expression and T stage in human GBC (Figure S2); knockdown efficiency of CDK7 siRNA (Figure S3); representative flow cytometry data of apoptosis analysis of GBC cells after CDK7 inhibition (Figure S4); apoptosis analysis of GBC cells treated with siCONTROL+DMSO, siCDK7+DMSO, or siCONTROL+THZ1 for 48 h (Figure S5); the effects of CDK12/13 siRNAs on cell proliferation, apoptosis, and the cell cycle in GBC (Figure S6); the knockdown efficiency of JUN or FOSL1 siRNA (Figure S7); characterization of 8P4 polymer (Figure S8); cellular uptake behavior of NPs in GBC cells (Figure S9); the synthetic route of bio-THZ1 (Figure S10); characterization of bio-THZ1 (Figure S11); the cell-based assay of Bio-THZ1 (Figure S12); tumor targeting efficiency of NPs in vitro (Figure S13); the concentrations of serum alanine aminotransferase (ALT), creatinine (Cr), and blood urea nitrogen (BUN) in different treatment groups (Figure S14); sequences of siRNA and primers used for experiments in this study (Table S1) (PDF)This article has not yet been cited by other publications.
materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology